UB Paderborn / Katalog / Suche / in CDI

The Skin Microbiome: A New Actor in Inflammatory Acne

American journal of clinical dermatology, 2020-09, Vol.21 (Suppl 1), p.18-24

2020

Link zum Volltext

Verfügbarkeit prüfen

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

Clinical cancer research, 2016-06, Vol.22 (12), p.2908-2918

2016

Link zum Volltext

Verfügbarkeit prüfen

Skin microbiome and acne vulgaris: Staphylococcus, a new actor in acne

Experimental dermatology, 2017-09, Vol.26 (9), p.798-803

2017

Link zum Volltext

Verfügbarkeit prüfen

Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab

Clinical cancer research, 2016-10, Vol.22 (19), p.4848-4858

2016

Link zum Volltext

Verfügbarkeit prüfen

Bacterial extracellular vesicles: A new way to decipher host‐microbiota communications in inflammatory dermatoses

Experimental dermatology, 2020-01, Vol.29 (1), p.22-28

2020

Link zum Volltext

Verfügbarkeit prüfen

Decrease in Diversity of Propionibacterium acnes Phylotypes in Patients with Severe Acne on the Back

Acta dermato-venereologica, 2018-02, Vol.98 (2), p.262-267

2018

Link zum Volltext

Verfügbarkeit prüfen

Nanosecond electron pulses in the analytical electron microscopy of a fast irreversible chemical reaction

Nature communications, 2019-08, Vol.10 (1), p.3648-8, Article 3648

2019

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy efficacy after first-line immunotherapy in 18 advanced melanoma patients

Medicine (Baltimore), 2020-07, Vol.99 (29), p.e21329-e21329

2020

Link zum Volltext

Verfügbarkeit prüfen

The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion

PloS one, 2012-07, Vol.7 (7), p.e40378

2012

Link zum Volltext

Verfügbarkeit prüfen

Circulating Tumor DNA Early Kinetics Predict Response of Metastatic Melanoma to Anti-PD1 Immunotherapy: Validation Study

Cancers, 2021-04, Vol.13 (8), p.1826

2021

Link zum Volltext

Verfügbarkeit prüfen

Severe Late-Onset Grade III-IV Adverse Events under Immunotherapy: A Retrospective Study of 79 Cases

Cancers, 2021-09, Vol.13 (19), p.4928

2021

Link zum Volltext

Verfügbarkeit prüfen

TLR-2 Recognizes Propionibacterium acnes CAMP Factor 1 from Highly Inflammatory Strains

PloS one, 2016-11, Vol.11 (11), p.e0167237-e0167237

2016

Link zum Volltext

Verfügbarkeit prüfen

Double Positive CD4CD8 αβ T Cells: A New Tumor-Reactive Population in Human Melanomas

PloS one, 2010-01, Vol.5 (1), p.e8437

2010

Link zum Volltext

Verfügbarkeit prüfen

Quantitative monitoring of circulating tumor DNA predicts response of cutaneous metastatic melanoma to anti-PD1 immunotherapy

Oncotarget, 2018-05, Vol.9 (38), p.25265-25276

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients

Cancer Immunology, Immunotherapy, 2021-10, Vol.70 (10), p.3015-3030

2021

Link zum Volltext

Verfügbarkeit prüfen

In vitro modulation of TLR-2, CD1d and IL-10 by adapalene on normal human skin and acne inflammatory lesions

Experimental dermatology, 2007-06, Vol.16 (6), p.500-506

2007

Link zum Volltext

Verfügbarkeit prüfen

Histopathological aspects of cutaneous erythematous‐papular eruptions induced by immune checkpoint inhibitors for the treatment of metastatic melanoma

International journal of dermatology, 2017-05, Vol.56 (5), p.527-533

2017

Link zum Volltext

Verfügbarkeit prüfen

Photodynamic therapy with methyl-aminolevulinic acid for paucilesional mycosis fungoides: A prospective open study and review of the literature

Journal of the American Academy of Dermatology, 2013-12, Vol.69 (6), p.890-897

2013

Link zum Volltext

Verfügbarkeit prüfen

Blood Predictive Biomarkers for Nivolumab in Advanced Melanoma

Acta dermato-venereologica, 2018-01, Vol.98 (4), p.406-410

2018

Link zum Volltext

Verfügbarkeit prüfen

Emergence of High-Avidity Melan-A-Specific Clonotypes as a Reflection of Anti-PD-1 Clinical Efficacy

Cancer research (Chicago, Ill.), 2017-12, Vol.77 (24), p.7083-7093

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Spironolactone Compared with Doxycycline in Moderate Acne in Adult Females: Results of the Multicentre, Controlled, Randomized, Double-blind Prospective and Parallel Female Acne Spironolactone vs doxyCycline Efficacy (FASCE) Study

Acta dermato-venereologica, 2024-02, Vol.104, p.adv26002-adv26002

2024

Link zum Volltext

Verfügbarkeit prüfen

An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial

Oncoimmunology, 2020-01, Vol.9 (1), p.1738812-1738812

2020

Link zum Volltext

Verfügbarkeit prüfen

Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trial

Cancer Immunology, Immunotherapy, 2020-08, Vol.69 (8), p.1663-1672

2020

Link zum Volltext

Verfügbarkeit prüfen

PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapy

Journal for immunotherapy of cancer, 2020-11, Vol.8 (2), p.e001631

2020

Link zum Volltext

Verfügbarkeit prüfen

Is a Single BRAF Wild-Type Test Sufficient to Exclude Melanoma Patients from Vemurafenib Therapy?

Journal of investigative dermatology, 2014-05, Vol.134 (5), p.1468-1470

2014

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

The Skin Microbiome: A New Actor in Inflammatory Acne

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

Skin microbiome and acne vulgaris: Staphylococcus, a new actor in acne

Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab

Bacterial extracellular vesicles: A new way to decipher host‐microbiota communications in inflammatory dermatoses

Decrease in Diversity of Propionibacterium acnes Phylotypes in Patients with Severe Acne on the Back

Nanosecond electron pulses in the analytical electron microscopy of a fast irreversible chemical reaction

Chemotherapy efficacy after first-line immunotherapy in 18 advanced melanoma patients

The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion

Circulating Tumor DNA Early Kinetics Predict Response of Metastatic Melanoma to Anti-PD1 Immunotherapy: Validation Study

Severe Late-Onset Grade III-IV Adverse Events under Immunotherapy: A Retrospective Study of 79 Cases

TLR-2 Recognizes Propionibacterium acnes CAMP Factor 1 from Highly Inflammatory Strains

Double Positive CD4CD8 αβ T Cells: A New Tumor-Reactive Population in Human Melanomas

Quantitative monitoring of circulating tumor DNA predicts response of cutaneous metastatic melanoma to anti-PD1 immunotherapy

Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients

In vitro modulation of TLR-2, CD1d and IL-10 by adapalene on normal human skin and acne inflammatory lesions

Histopathological aspects of cutaneous erythematous‐papular eruptions induced by immune checkpoint inhibitors for the treatment of metastatic melanoma

Photodynamic therapy with methyl-aminolevulinic acid for paucilesional mycosis fungoides: A prospective open study and review of the literature

Blood Predictive Biomarkers for Nivolumab in Advanced Melanoma

Emergence of High-Avidity Melan-A-Specific Clonotypes as a Reflection of Anti-PD-1 Clinical Efficacy

Efficacy of Spironolactone Compared with Doxycycline in Moderate Acne in Adult Females: Results of the Multicentre, Controlled, Randomized, Double-blind Prospective and Parallel Female Acne Spironolactone vs doxyCycline Efficacy (FASCE) Study

An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial

Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trial

PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapy

Is a Single BRAF Wild-Type Test Sufficient to Exclude Melanoma Patients from Vemurafenib Therapy?

Suchergebnisse filtern